ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weng, Y.-C.
Right arrow Articles by Lin, W.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weng, Y.-C.
Right arrow Articles by Lin, W.-S.
Annals of Clinical & Laboratory Science 35:259-264 (2005)
© 2005 Association of Clinical Scientists

CT60 Single Nucleotide Polymorphism of the CTLA-4 Gene Is Associated with Susceptibility to Graves’ Disease in the Taiwanese Population

Yu-Ching Weng1,2, Ming-Jiuan Wu2 and Wei-Sen Lin3
1 Clinical Laboratory, SinLau Christian Hospital; 2 Biotechnology and 3 Hospital Management Departments, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan

Address correspondence to Dr. Ming-Jiuan Wu, Department of Biotechnology, Chia-Nan University of Pharmacy and Science, Tainan 717, Taiwan, ROC; tel 886 6 266 4911 ext 220; fax 886 6 266 6411; e-mail: imwu{at}mail.chna.edu.tw.

Graves’ disease (GD) is an autoimmune disease but the underlying etiology has not been completely elucidated. Genetic susceptibility has been believed to play a major role. Recent studies showed that the CT60 single nucleotide polymorphism (SNP), which is in the 3'-noncoding region of the CTLA-4 gene, is strongly associated with some immune-mediated diseases. The aim of this study was to test for association between GD susceptibility and polymorphisms of CTLA-4 (ie, the CT60 SNP and the exon 1 +49 SNP) in the Taiwanese population. Our results demonstrate significant differences in the frequencies of the genotypes and alleles between 107 GD patients and 101 control subjects in the CT60 and exon 1 +49 SNPs (p <0.05). Significant differences in phenotypes were only found for CT60 SNP (78.4% vs 67.8% between patients and controls; {chi}2 = 3.93, p = 0.047). Furthermore, we found that the G/G genotype of both CT60 and exon 1 +49 was associated with increased risk for GD (p = 0.022, OR = 1.97). Significant linkage disequilibrium was found between the CT60 SNP and the exon 1 +49 SNP in both GD patients and control subjects (D’ = 1.00). Because of tight linkage disequilibrium, a combination of these SNPs enhanced the role of the CTLA-4 gene in GD. The frequency of the disease-susceptible G allele of CT60 was comparable to that in Japanese and higher than in Caucasians. In conclusion, we provide evidence that CT60 SNP is associated with susceptibility to GD in the Taiwanese population.

Keywords: CT60 SNP, CTLA-4, exon 1 +49 SNP, Graves’ disease, single nucleotide polymorphism




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D. A. Chistiakov, I. Frydecka, A. Ghaderi, S. C. Gough, Y. Hiromatsu, R. Ploski, et al.
Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-W. Wang, I-Y. Chen, R.-T. Liu, C.-J. Hsieh, E. Hsi, and S.-H. H. Juo
Cytotoxic T Lymphocyte-Associated Molecule-4 Gene Polymorphism and Hyperthyroid Graves' Disease Relapse after Antithyroid Drug Withdrawal: A Follow-Up Study
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2513 - 2518.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association of Clinical Scientists.